Treatment with Cana at 10 mg/kg and 20 mg/kg reduced TGF-β1 levels to 53.9% and 30.9% of the HCC group, respectively (p ≤ 0.05) (Fig. 5). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.